Taylor, CFO of Recursion Pharmaceuticals, sold $89k in shares




Taylor, CFO of Recursion Pharmaceuticals, sold $89k in shares



Source link

  • Related Posts

    Provexis reported lower half-year earnings amid production delays

    Provexis reported lower half-year earnings amid production delays Source link

    RLX Technology Extends $500 Million Share Repurchase Program Through 2027

    RLX Technology Extends $500 Million Share Repurchase Program Through 2027 Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *